Aids/HIV information, Symptoms, treatment

HIV infection is a sexually transmitted disease (STD) or sexually transmitted infection (STI): this means that a person infected with HIV can infect sexual partners regardless of their sexual attractions, whether heterosexual or homosexual. A single unprotected intercourse may be sufficient to contaminate her partner. A person who is infected by the AIDS virus is often healthy for several months or even years. It is a carrier of the virus and can transmit it to his sexual partners without knowing if sex is not protected.

The risk of HIV infection is increased, especially if the sexual partners are numerous, during sex with a partner whose unusual is not known HIV status, if one partner shows a lesion of the skin or mucous membranes (genitals, anal) where HIV enter more easily and always when sex is not protected.
Even today, despite the messages of prevention and health education, too many people infected by the AIDS virus are found only at the stage of the disease AIDS, not only salaries but are less effective and more, they risk spreading the virus throughout the period of ignorance of their infection if they did not use condoms during sex.
That is why screening for infection is a crucial test when driving at risk. There are other routes of transmission of the AIDS virus:
The transmission of AIDS/HIV through blood
In people suffering from disease requiring a blood transfusion: contaminating blood transfusions are rare today, at least in industrialized countries, preparations and the controls on blood donations being draconian. Among drug addicts who inject drugs intravenously with equipment already used and stained by the blood of an infected person. At the nursing staff because of an accidental exposure to blood, for example, if the person pique with a needle that has already been used on an infected person or projection of blood or body fluid containing HIV.

The transmission of the virus from infected mother to her child is also possible during pregnancy or during childbirth. As the virus is present in breast milk, the mother can transmit the virus to her baby if baby breastfeeds.

AIDS (Acquired Immune Deficiency Syndrome) is an infectious disease, viral chronic, characterized by declining defenses of the body. This leads to the emergence of opportunistic diseases, which are so called because they benefit from the progressive inability of a sick person to defend themselves in order to develop these opportunistic diseases are represented by certain infections or cancers, which will weaken further the agency reached.

The virus responsible for AIDS disease is called the AIDS virus or HIV (Human Immunodeficiency Virus).
What characterizes this infection is that it moves silently on a chronic: a person with HIV is not the disease AIDS immediately, it may take several years before the disease does occur.

HIV infection is contagious, even when the infected person is not ill, it can transmit the virus. Transmission is a human being (man or woman) to another human being (man or woman), mostly on the occasion of unprotected sex with an infected partner.
Therefore, it is a sexually transmitted disease (STD). The only means of prevention is the protection of partners during sex with condoms when you do not know their HIV status and that of his partner, if condoms are not used, we talk about relative to risk.
A pregnant woman infected with HIV can transmit the virus to the child she is carrying. The transmission can be done by blood, mostly by sharing a syringe contaminated.
If a person has been infected by the AIDS virus, the virus is present in his body and will be HIV-positive vis-à-vis the virus, ie it has produced antibodies against the virus, HIV.
As long as a body has not been in contact with the AIDS virus, it will be HIV-negative.

A person infected with the AIDS virus, introducing the disease AIDS or not, treated or not, must be monitored regularly by a doctor.

Today through research, new drugs have been on the market, therapeutic protocols were refined. The triple therapy, ie the combination of 3 drugs prescribed simultaneously, as recommended by the experts can reverse the disease AIDS, HIV infection has become a chronic condition. The global AIDS epidemic began in the eighty years. Today, almost 40 million people are infected: homosexual, heterosexual men, women and children. Millions have already dead. Many children are orphans of father, mother or both, died of AIDS. Almost one million are infected.
The African region sub-Saharan Africa is particularly affected.

HIV infection is moving inexorably towards the AIDS disease . AIDS is represented by the emergence of diseases signing a loss of patient capacity to defend itself against infectious diseases and cancers. They are called opportunistic diseases.
AIDS worse when CD4 T cells are too low to enable the organization to defend themselves infected against bacteria or viruses into contact with the body weakened, and may appear tuberculosis, toxoplasmosis, candidacies, a mononucleosis infection, shingles,. Similarly, abnormal cells may no longer be destroyed and cancer will develop more easily.
The decrease in lymphocytes will allow HIV to grow even more easily and more low defenses.

Changes in the number of viruses and defenses in the absence of antiretroviral treatment

Current treatments against HIV help reduce its propagation, the point of rendering the virus undetectable by means of blood test today. But these antiviral treatments do not cure patients infected with HIV, a body infected with HIV keep life and he will always be contaminant even though the virus seems, given blood tests, have “disappeared”.

The goal of treatment, when taken correctly, is: completely control the virus replication: the extent of the viral load in the blood shows that the virus is undetectable. restore the body’s defenses: the extent of CD4 lymphocytes in the blood shows that they are increasing

The greatest organization of women of the world, YWCA summons the Summit the International of Women in Nairobi, Kenya, from the 1 to the 11 of July. This world-wide event without precedents will reunite more than 1500 people, in its majority women, who work actively in diverse sectors to create solutions to the impact that infection VIH and AIDS has on the women and the children. Many of them work in local communities affected by the infection The event that is celebrated in the Center the International of Kenyatta Conference in Nairobi aims to share experiences and evidences so that as much the individuals as the organizations can develop to abilities and knowledge and elaborate effective programs of fight against the disease in concrete realities where usually they are scarce resources and qualified personnel. By their traditional function in the family and by its activism, the women honor how local leaders and are marking to the difference in the fight against the VIH and the AIDS.

The agenda of work of the Summit anticipates the accomplishment of diverse factories and forums on essential subjects like the action on local policies and mechanisms of legal defense, the prevention and the treatments, the cares and support to the infected women and children, the lessons learned in the years of work already developed in the communities. Also Women will give themselves to prizes “Leading the Change” with which tribute to the women will surrender who have led the local work in the prevention areas, taken care of and treatments, defense and formulation of policies of sort equality, estigma and discrimination.   There will be two categories by each prize: the recognition of leaders rooted in its community and the sprouting of new leaders between the women. Posted in AIDS /HIV, activists, education. Comments “Does not fight the AIDS with the microcredit June 18, 2007 - MIGAS the agency of microcredit Pla Net Finance has decided to undertake in Morocco a sanitary program directed to more than 10,000 illiterate women for the prevention of the SIDA/HIV. The interest of the agencies of microcredit by the sanitary education comes for two reasons just: first, that the 76 percent of women infected by the SIDA/HIV lives in Africa and the statistics have put in evidence that while the average rate of solution of the microcedits is in the 98 percent, this one can lower until the 68 percent in areas particularly struck by the disease. The second reason is that most of the beneficiaries of microcredits they are women. It is not the first time that the sanitary programs of education have taken advantage of the microcédito like vehicle diffusion and approach to the population. The Finance for Trust the Self-Employed (FITSE), subsidiary of World Vision International in Malawi, has sent to the program ` Credit with Educacion’ that in 12 sessions teaches to the women to prevent the infection and to transmit these guidelines to its community.   

According to the director of the agency of microcedit PlaNet Finance, it is possible to unite the financial services to programs of training and education of the health in areas where infection SIDA/HIV is very high. The women represent most of the beneficiaries of the microcredits and can develop to a central paper in the prevention of the diseases and the maintenance of the health of the family and whole communities. With its program in Morocco, PlaNet Finance wants to demonstrate, in addition, that it is possible to design adapted programs of microfinancing to the special exigencies of the people infected with AIDS/HIV. Posted in AIDS /HIV, banks, economy, microcredit, poverty. Comments “Brazil and Thailandia do not break patents of the pharmaceutical industry May 28, 2007 - MIGAS the Government of Brazil has decided to impose a” obligatory patent “to the drug efavirenz, considered like one of the most effective tools to fight the infection by VIH. Brazil will concern the generic one produced by laboratories of India, that costs less of a third of which it produces the pharmaceutical multinational Merck Sharp&Dhome.

The decision has been answered by the Federation the International of the Industry of the Medicine, that considers that “it is not a solution that improves the access to medicines”. “we are taking an important step and the decision is worth for this remedy and any other when it is necessary. Today he was this one and tomorrow he will be another one. If we did not obtain the right prices, we will make that decision “, has been the answer of the Brazilian president, Luiz Inácio Lula gives Silva. With this measurement the Government of Lula can assure treatment to 75,000 infected.    

The Merck multinational receives to the Government of Brazil 1.59 dollars to him by unit of the drug while in Thailand the same drug costs 0.65 dollars the unit. According to the Ministry of Health, the price applied by the laboratories that make the generic one in India is of only 0.45 cents by unit. The annual treatment by patient with the drug of Merck reaches the 580 dollars whereas the same treatment with the generic drug hill 165 dollars to the year, less of a third. The minister of Health, Jose Gomes Temporao, informed that before imposing the obligatory license, the Government of Lula had rejected the offer of Merck to reduce in a 30% the price of the drug, when considering that the reduction of the price had to be at least of 60%. The obligatory license is predicted in the international agreements: it is applied to those patents that fulfill certain conditions and implies that the authorities can grant to license to companies or people different from the holder of the patent so that these make use of the rights of the patent and can make, use, sell or concern a product protected without the permission of the holder of the patent.

Countries such as Italy or Canada also has granted “obligatory licenses” on pharmaceutical products, according to the mechanism anticipated in the Agreement on the Aspects of the Related Rights of Intellectual Property to Comerce, of the World-wide Organization of Commerce. Cheap generic the medicine production based on formulas protected by patent is a practice allowed by the World-wide Organization of Comerce from 2001. In December of 2006 the Government of Thailand announced that he was going to emit a license obligatory to assure that the people infected by VHI could accede to a the generic one of efavirenz, produced by laboratories of India, the same drug that today is object of the obligatory patent emitted by Brazil. In May 2007 Thailand stayed signs as opposed to the pressures of the phamacists, which seems to have opened a breach in the world-wide rules of commerce that could animate to more countries in via of development to break patents in case of emergencies of the public health.

The newness to emphasize is that the Government of the U.S.A. has clarified that Bangkok has not broken any law according to the special dispositions in the Agreement of the OMC on the Aspects of the Rights of Intellectual Property related to Comercio. The office of commercial representation of the United States (USTR) had put to Thailand in a gray list of countries that have violated in some degree the intellectual property and now will have to erase it of the list. Thailand broke the patent of efavirenz imposing an obligatory license, soon did the same with other two drugs for the treatment of patients infected by SIDA-HIV. In the last years, India has become a generic medicine source. According to the humanitarian organization Medical Without Borders, 84% of the medicines that MSF uses to treat the AIDS in more than 30 countries generic are produced in this country. Posted in AIDS /HIV, phamacists, investigation, poverty, intellectual property.

The agency of microcredit Pla Net Finance has decided to undertake in Morocco a sanitary program directed to more than 10,000 illiterate women for the prevention of the SIDA/HIV. The interest of the agencies of microcredit by the sanitary education comes for two reasons just: first, that the 76 percent of women infected by the SIDA/HIV lives in Africa and the statistics have put in evidence that while the average rate of solution of the microcedits is in the 98 percent, this one can lower until the 68 percent in areas particularly struck by the disease.

The second reason is that most of the beneficiaries of microcredits they are women. It is not the first time that the sanitary programs of education have taken advantage of the microcédito like vehicle diffusion and approach to the population. The Finance for Trust the Self-Employed (FITSE), subsidiary of World Vision International in Malawi, has sent to the program ` Credit with Education’ that in 12 sessions teaches to the women to prevent the infection and to transmit these guidelines to its community. According to the director of the agency of microcedits PlaNet Finance, it is possible to unite the financial services to programs of training and education of the health in areas where infection SIDA/HIV is very high.

The women represent most of the beneficiaries of the microcredits and can develop to a central paper in the prevention of the diseases and the maintenance of the health of the family and whole communities. With its program in Morocco, PlaNet Finance wants to demonstrate, in addition, that it is possible to design adapted programs of microfinancing to the special exigencies of the people infected with AIDS/HIV.

According to the WHO (World-wide Organization of the Health), about 2.5 African million of Sub-Sahara have AIDS. Africa is, apparently, in the claws of a AIDS pandemic. (In the United States 300,000 people are listed like cases of AIDS).

The AIDS in Africa is portrayed like providing two important lessons for the West. First it is an example of the potential devastation that could untie the AIDS; second it is that by means of I infect heterosexual, the AIDS will finish seizing of the West. Nevertheless, convincing evidence of which million of African are infected with HIV, the putative cause of the AIDS, or of which I infect and distribution of the AIDS of Africa does not exist has a heterosexual origin.

The only evidence of some African “is infected” with a HIV virus is indirect, being based on the random test of the blood of African discovering the presence of antibodies that react with a series of the calls “proteins HIV”.  If “proteins HIV” (present in kits of test) only reacted with antibodies HIV, there would not be any problem. Unfortunately, this it is not the case. The antibodies produced in answer to the presence of some strange agent can also react with other different strange agents; and the infectious agents to whom a person has been exposed, greater are the possibility that those antibodies of crossed reaction exist.

The discarding of the reactions crossed between “proteins HIV” and the plethora of other present antibodies in the individuals that are exposed of constant way the microbial agents, can only be obtained determining the exactitude of the correspondence between the reactions of the antibodies and the presence or absence of the pure HIV, in itself. In other words, an isolated viral preparation of well-known purity like a “Standard one of Gold” for the reactions of antibodies is due to use. This was never made, or in Africa or in the West, Of such way, nobody knows with security if in Africa the tests of antibodies are specific for the HIV, that is to say, if a positive result really means an infection HIV. Many experts in African AIDS still accepted this fact in the beginnings of the era of the AIDS.    At the beginning of this years Myron Essex, an important investigator and his colleagues of the University of Harvard, when they discussed his experimental datas on tests of the antibody of the AIDS in Africa, again warned that tests of antibodies “can not be sufficient for the diagnosis of HIV in the endemic areas of AIDS of the Central Africa, where the prevalence of microbacterial diseases (leprosy, tuberculosis, malaria and others whose antibodies can give crossed reactions) is extremely high.” Thus, the certainty that does not exist the African really are infected with a new putative agent, HIV. The experts in AIDS also agree in which the acquired immunological deficiency (the “GOING” in AIDS) also has a data in Africa.

The immunological deficiency can be caused by undernourishment, certain virales infections, and diseases like the malaria and the tuberculosis, all which knows that they exert a strong depressive action on the immunological system. Unlike the West, the AIDS in Africa is diagnosed without no type of laboratory test. The patients classify themselves like cases of AIDS without the laboratory tests that they have, or immunodeficiency or a HIV infection. Everything what is required is to have several clinical conditions.    But the accepted conditions to form the “S” (syndrome) of “AIDS” in Africa, do not have any relation with the AIDS in the West. In the West, the AIDS is diagnosed if a person has one or more of approximately 27 relatively rare diseases. Nevertheless, the AIDS diagnoses in Africa in agreement the definitions “Bangui 1989/87″ of the WHO that can be described better like a set of nonspecific common symptoms, like cough, fever, diarrea, tuberculosis (TB) and a cancer known like “sarcoma Kaposi”. Tdas these diseases have been endemic in Africa for centuries. Sarcoma Kaposi, for example, was described in the dated

Ebers papyruses in 1600 before Christ. (In the West, sarcoma Kaposi is restricted the homosexual men). Of the 661 million people in Sub-Sahara Africa, of 2 to 3 million they have an active tuberculosis with an annual mortality of 790,000 people. In spite of this and of the fact that in the adults infection HIV normally follows the TB infection; the tuberculosis has now become a disease that it defines to the AIDS. In fact, from the 30 to 50% of the deaths by African AIDS they are by tuberculosis. Despite all this, the experts in AIDS hope that we accept that something “new” has desem-bacado in Africa and that it is caused by a new agent, HIV. Suddenly, a new enfer-mdad, caused by a new agent has appeared. The old diseases and their pernicious effects on the immune system no longer are more operative.   Many experts in AIDS also hope that we created that, unlike history in the West, Africa the AIDS expands of predominant way, by heterosexual contact. In truth, since the number of cases in the West is too small to be statistically significant, the “African evidence” is used to foretell the same predicament in the West. The affirmation of the heterosexual expansion in Africa is based on the “absence of homosexual transmission or intravenous drugs”, and approximately the equal number of seropositivos men and women who also have AIDS like tests for antibodies. This last certainly test that the AIDS has a heterosexual expansion - the influenza and the appendicitis does not have also the same distribution in sexes. Given the beacon of which tests of seropositivos antibodies can be due to the presence of antibodies formed in answer to the malaria, tuberculoses, leprosy, and many parasitic diseases, are not surprise that an equal number of men and women will be diagnosed with “AIDS” according to symptoms that have centuries of antiquity, and have a positive test of antibodies. In any case, the theory that AIDS in Africa is transmitted of heterosexual way creates more problems for theory HIV of the AIDS that those that solves. One says that a disease is caused by a sexual signal officer if one of the infected parts, we say the active part (the man) transmits the agente/enfermedad to the passive part (woman), that another man as well transmits to the agente/enfermedad. This is, the diseases of sexual transmission are transmitted bidirectionally, of man to woman to man. In the West, the studies epidemiologists greater (thousands of cases), lead of the most judicious way, have proven beyond any reasonable doubt that, as much in men as in women, the only act that take to the acquisition of “antibodies HIV” (women) and “antibodies HIV” and possible AIDS (homosexual men) it is the passive anal copulación (receptive). In other words, in the West, the “antibodies HIV” and the AIDS, miso that the pregnancy, only can be acquired by the passive partner. If, the other way around of the pregnancy, “antibodies HIV” are not caused by a noninfectious agent (sperm, semen) but by HIV, then the HIV will be the only transmitted infectious agent unidirectionally by means of sex. The active member will have to acquire to the HIV by other means.   This is enough stranger: in all the history of the medicine never there was a agente/enfermedad of sexual transmission that has been transmitted of unidirectional way in the West and bidirectionally in Africa. Only the other alternative to this ridiculous scene is to be in agreement with seropositivos the African doctors who tests of HIV in Africa do not mean infection with, and which the inmunodepre-sión and certain symptoms and diseases that constitute the African AIDS have existed in Africa from immemorial times. In agreement with Professor P.A.K. Addy, head of Clinical Microbiology of the University of Science and Technology, in Kumasi, Ghana: “European and the Americans come to Africa with prejudiced minds, so that they are seeing what they want to see… I have known for a long time that the AIDS is not a crisis in Africa, as it has been wanted to him to make include/understand to the world. But in Africa it is very difficult to stretch the neck and to say some things. The West came with all those terrifying statistics on the AIDS in Africa because it was not to as much of certain social and clinical conditions. In most of Africa, the infectious diseases, in individual the parasitic ones, are common. And there are other conditions that can jeopardize with facility or affect the immunological system.”    The Dr Konotey-Ahulu, of the Cromwell Hospital of London, expresses a similar vision: “At the moment, because of the AIDS, it seems that to the African more is not allowed them to die because of these conditions [ of which was used to dying before the era of the AIDS ]. If tens of thousands are dying of AIDS (and the African they do not cremate to its deads) where they are the tombs ” According to him, the most important question in the mind of African and European the intelligent ones in that continent is: “Why the means of press of the world seem to have conspired with some scientists to have turned so gratuitously outlandish with the lie”

This description is the more technical of two documents. The other document is called A TREATMENT FOR AIDS. Please read that document first.

AIDS is a social issue. Throughout the world it affects millions of individuals in a variety of living conditions and in societies of varying incomes and resources. A successful treatment for the disease must be available to these persons in an effective form. The goal of this article is to outline how clinical treatment can be accomplished world wide in a period of less than two years from today

The creation of a treatment program consists of determining the configuration of a single machine to combat the disease, to duplicate the machine in the thousands, to distribute the devices in a clinical environment, and to make the individuals aware of their availability. The machine is a simple design. It extracts blood from the client at a continuous rate, creates a set of interference grids through which the blood passes, and returns the blood to the client, cleansed of adult HIV. Extracting blood and transporting it through the process is not a difficult task. Our current application of clinical kidney dialysis has already solved much of the mechanics. Since the advent of diagnosed AIDS, the process that prevents viral contamination between clients has also been resolved. The basis of my clinical approach is the adaptation of techniques used in clinical dialysis.

What must be developed is the actual mechanics of presenting the blood to the interference grids, and to develop these grids into effective mechanisms. Separating the actual blood from the machine’s active elements appears to be the standard form of minimizing cross-contamination between clients. The physical conductor of the blood through the device would appear to best be in a disposable form, or in a form that is individual to the client. The clinical process of preparing the equipment for the next client would involve the removal from the machine of the conductor, and its replacement that is unique for this treatment session (disposable), or is the conductor assigned to the individual client. These alternatives will be determined by the economics of the clinical environment. The conductor would consist of what is essentially a tube that is responsible for accepting the blood from the extraction catheter, transporting it through a pumping apparatus, carrying the blood through the interference grid section, and discharging the blood into a return catheter to complete the circuit. It must be flexible to permit the pumping section to function through its walls, and in the grid section, it must provide the maximum transmission of the patterns into the blood.

The conductor, then is to be a blow-molded plastic vessel that may contain some very specific geometry, and in some sections would have a very specific thin-walled profile (grid section). By using blow-molded conductors ensures the minimum cost-per-client for the clinical process. These conductors may prove to be a difficult thing to mass produce using blow-molding techniques, but the technology available to the industry indicates there to be no barrier here to the development of the clinical system. To understand the grid section that actively destroys the virus cells requires a grasp of the physics and the medium. The physics again is simple in concept. A set of light beams is emitted by individual lasers. The beams travel from the lasers through the membrane wall of the plastic conductor, and through the blood. These lasers are positioned in sets to permit each set’s beams to intersect while passing through the blood. The region in the blood where a set of beams intersects is an individual grid, and each grid slices a cross section of the blood as it travels inside the grid section. The optimal condition for these grids is for each grid to occupy an entire cross section of the conductor, allowing no blood to pass through the conductor that does not travel within each individual grid. Thus all the blood will pass through each grid. The grids are to be lined up along the conduit’s path in the grid section.

 
Each beam is created by one laser. Lasers are to be used for their stability of emitted frequency. This stability must be maintained to a high level of confidence, and my opinion is that the temperature of the lasers will require some form of external regulation. Thus, a water bath or some more elegant means of temperature control for the lasers of the grid section will be included in the clinical machine. 
As the beams converge within the blood, their discrete frequencies dissolve into each other in a manner described by a very specific mathematical model of interferometry, which is a large word, but a well-understood physics principle. Lasers themselves could not be designed without this understanding. Diode lasers or some similar forms of solid-state lasers are indicated. Here again, every compact disk player has a diode laser that reads the disk. The technology is well known and easily applied to the clinical application. The mathematical model is the key, and actually the only real research required to institute this program.  
The model then consists of a generated field in space (the grid section) in which the beams converge and blend, with the result being a region filled with energy that cavitates matter in three dimensions. Roughly, the waves of the converging beams act upon each other to create pockets that are sized to mimic the volume of individual adult HIV virus shells (virophage). The energy of the beams is discharged into all of the physical components of blood as each travels through the grid. In a properly configured grid, the form of energy presented to the blood’s components is easily absorbed by the human components, but the viral material sustains sympathetic vibration related directly to size, and are fractured or pulverized. By supplying sufficient energy, the assurance of total destruction of the included virus cells is possible, returning only dead adult virus to the body as the client’s blood is returned.
Blood contains many components that react to the beams by absorbing them, reducing effectiveness. Each of the major blood components requires a set of beams and a discrete grid. Their combined obstruction to the process is eliminated. Red corpuscles absorb one band of light and transmit others. By tailoring one grid to accommodate the red cells, their obstruction is eliminated. Another grid is tuned to the best frequency family to ignore the white blood cells. This selection of grid frequencies can become as detailed as needed to prove clinically effective. By encompassing the scope of blood components and including individual grids in the grid section for each, the clinical device can ensure that the exposure of no viral cells is occluded by adjacent human structures. Since there is very little resemblance between the physical size and shape of viral cells and those of human blood, there is a very great expanse between the threshold of this type of energy required to destroy the viral cells and the minimum energy required to injure human blood cells. It means that once the proper frequency sets and patterns are mathematically developed, constructed and applied, there is very little risk of damaging the blood. The amplitude and intensity that may be applied, range to the level of brutal to the viral cells, yet the blood will be unaffected. 
The choice of frequencies is a matter of physics. Interferometry is based upon the blending of two or more separate frequencies. To create the energy boxes of so small size requires that the set of frequencies for each grid be of emissions of a very small frequency separation for each grid. The band for each grid’s emissions is very broad. It means that the frequency selection is almost open. Light frequencies are indicated since they do not harm human cells and are shown to destroy virus cells. Within that band, the choice is unlimited. Harsh x-rays or hard ultra violet frequencies need not be used. 
Cost of these grids is almost negligible in mass production, easily less than one or two thousand American dollars per grid section. The financial issue is based upon the determined requirements for the electrical and thermal conditions of the components. This may prove to be sizable, as stability in this process is paramount, especially when combined with the prerequisite necessity to perform in adverse and varietal international conditions. To be clear, the electrical and thermal requirements are not in need of new technology, they are just expensive. Another advantage to this clinical process is that it can cheaply, rapidly and easily be reconfigured to be effective against any virus form, once the virus cell’s physical configuration is known. It can be adapted to mutations, though I believe that the original device will prove effective for all forms of HIV at once. This feature permits the shipment of these machines to the crisis center of any new virus outbreak, where they can be configured in the field with minor software or hardware refit, and be effective in a time span of less than a week. One machine could see application toward a dozen virus species in a decade, and should be designed to do so. Philosophically, since the technology can combat viral leukemia and Ebola as readily as HIV, its funding and distribution are more acceptable in some social structures, and are universally justifiable.
The application of this clinical approach to virus-based crises is only a treatment, not a cure.  
Also, its process does not interfere with those measures of control through pharmaceuticals, and gives the client more opportunity to cultivate antibodies naturally. It may provide an individual with sufficient time to develop a clone-able antibody that would constitute a cure. When these grids increase in size to insert an entire human, then this clinical treatment becomes a cure.  
The pressure to enlarge the grid size will be driven by the industrial application of the technology. Since blood is a complex fluid, the conversion of clinical equipment to eliminate viruses from industrial fluids is simple, while keeping them chemically pure. The pharmaceutical industry requirements alone will drive development. Eventually, grids a meter across will control virus flow through both drains and water sources, improving the human condition. 
Development of this technology also does not interfere with the research being continued for biological treatment. The individuals involved and the equipment resources are different. This development program will use laser technology and electronics in separate laboratories. This treatment program will be independent of pharmaceutical programs, so no currently active resources will be compromised. 
There is a threat in our world for combatants to resort to viral warfare. Since the form of virus cannot be determined until the event, there are few means currently available for military medical staff to respond. This technology has the capability to treat the soldier in field hospital conditions, or in severe quarantine. The technology is configured to be portable, and can be useful in treatment within days of contamination. An armed service can for the first time expect that its soldiers in the field can be saved from this form of assault.
 

AIDS can be treated for now, and in the future be cured using the process described here. Most of the current uses of this technology are in another field of science, and the adaptation of use against viruses is a new idea.

Infectious viruses share an elemental life cycle that includes a period in which the virus is a protein shell that encloses DNA molecules, and which has a connector that attaches to human cells through which the virus can inject its DNA into the human cell. The key factor that indicates this treatment is that the efficiency of reproduction in viruses is primarily supported by that virus’s shell (called a virophage). Any strain of virus in a human will have only one size and shape for the shell for its entire population. So it is with HIV, and we can use this to destroy the virus because, of all the properties of the virus, HIV’s shape and size are the most significantly different physical factor from any and all human cells.

Thus far any process that guarantees the physical destruction of the DNA inside HIV will also affect human DNA. Viral DNA is only active when already inside a human cell and we have not found any manner to destroy it once active. The majority of research is trying to prevent closure between the virophage and our cells. This clinical process follows that approach using mechanical force rather than chemicals.
Physics creates a model that defines space in discrete three dimensional boxes and is capable of providing energy to these boxes, which is keyed to the volume of each box. The research would define those boxes to equal the volume of an HIV virophage. It would create an energy field and use the energy to destroy every virophage in the space. This type of physics is called diffraction, and it expresses the interference of conflicting waves.
Ocean waves can be exampled as they are watched from the beach. Surface energy comes toward the beach from many directions at once, and waves collide. As you walk along the beach, you can identify where the energies of all the waves combine to enhance each other; it is a huge, high wave front. Yet nearby, those same waves have not combined as well and cancel each other. This is a jumbled, turbulent, low area. For any wave form of energy, this concept is in place. With higher frequencies such as light, the event of the colliding of waves is referred to as diffraction.
The clinical process would create its own waves in a controlled chamber. These waves would use diffraction theory to distribute the energy into HIV virophage-sized boxes in the chamber, with enough power provided to each box to rupture or otherwise destroy the HIV virophage’s protein casing. As a virophage travels through the field, it assumes the space of one of the boxes and its shell resonates with the energy of the field. That resonance will shatter the shell. Since no human tissue even remotely contains that same volume, they will not resonate. In the human tissues, the energy is distributed, dissipated in a manner not possible for the virophage, which must absorb all the energy. As the energy passes through the blood it contacts all the human components, yet they aren’t the same size as the HIV virophage so the energy doesn’t “stick” to the red cells, the white cells, nor anything but HIV. When the energy does contact HIV, it shreds it at a molecular level.
Think about holograms. They are images created by interference patterns, and much research has been directed toward understanding their use of diffraction . A hologram’s image quality and resolution are a directly related to high-frequency, better-defined illumination sources, usually lasers. Holograms most viewed by the public are recorded in a thin layer of polymer, yet there are types of holograms that utilize a far thicker medium. Imagine a hologram that has as its subject, the HIV virophage. What I propose is very closely related to that concept.
Instead of generating a likeness of a virophage, we will project the interference pattern directly into a thick layer of blood as it passes through a machine. The interference is to create a phenomenon called ‘cavitation’ in a spatial volume level meant to match the HIV virophage. The cavitation contains enough energy to destroy each virus.
A well-known demonstration that this works is a commercial for audio tape. The televised version shows the First Lady of Music singing into a microphone. As the commercial progresses, the woman sings a single note for long duration. The amplified sound, which is emitted by an acoustic speaker, shatters a crystal goblet. Vibration causes the crystals to resonate within the goblet that tears it apart.
That vibration was created by an acoustic speaker whose active element is made mostly of paper. The glass is in most ways much stronger, but at selected frequencies it is far weaker. More importantly, the sound originated in human vocal cords and throat with no damage to either to break the glass, yet glass may readily cut flesh. So it is with the HIV. By selecting the proper frequencies to combine in the proper manner, the waves will pass through all else with little effect, yet they will be permitted to combine and crescendo along the surface of the HIV, tearing it apart.
Sunlight is jumble of frequencies that travel through space together. As these frequencies collide and mesh, they perform work on any material present at the event. This is how our eyes detect light, how sunlight’s infrared rays heat material. It is well known that simple sunlight destroys more viruses than any other factor in our lives. Sunlight is the natural enemy of viruses, and this clinical technology makes this effect more available to the HIV in blood.
There are many ways you can understand this technology in its more practical, every-day forms. Ask a medical ultrasound technician to explain how his instruments are capable of traveling through inches of skin and muscle, and in the midst of kidney nephron cells (some of your body’s most delicate and sensitive tissues) find and destroy hardened kidney stones. Ultrasonic jewelry cleaners use the principles to dissolve grime without affecting the metal or gems.
Theoretical understanding of diffraction theory has been around a very long time, yet the technology required to operate this in a clinical setting has only come to light in the past few years. The mechanics of creating a field of independent waves capable of this activity are challenging. Blood is full of human components that would scatter the waves and reduce the effectiveness. The need for funding to develop the clinical application will be significant.
This treatment is not limited to HIV. By identifying the volume of any virus, field and frequency adjustment can target any virus. Ebola, herpes, leukemia-forming viruses, the list begins here. My opinion is that in the course of killing the HIV in a sample, many or all the other adult viruses present may be destroyed.
Please notice I have used the word “TREATMENT” rather than cure. This process only destroys adult viruses, not affecting those in other phases of life cycle. What I propose is a clinical program that begins reducing the population of adult viruses in the client through a means similar to how we use kidney machines today. A client comes to a center, is hooked up to a machine that extracts his blood, cleanses it of HIV adult virophages, and returns it to him. After a cycle time shown to be effective, the machine is disconnected and prepared for the next client. Since the process is not chemical, concurrent treatment programs will not be affected. This clinical procedure becomes an additional tool to work beside pharmaceutical treatment without affecting them.
By actively reducing the quantity of HIV virophages in the client’s bloodstream, we reduce the effects of the virus. This would give the natural immune system a longer, greater chance to develop its own antiviral program and helps maintain the population of T-cells.
To do all this requires no large new breakthroughs in physical science. Diode laser technology need only be adapted to supply the waveforms and spatial relationships required. Most of us already use diode lasers (there is one in every compact disk player), and the versions required to do this work are only better defined and packaged.
 US government heavily subsidized a corporation that put HIV under an electron microscope, so we already have a very detailed geometrical survey of the surface. Actual models of the virus are well defined, with the orientation of the molecules known.
A cure using this technology would require the field to be large enough to envelop an entire animal. Since the life cycle of the virus is known, by administering the treatment repeatedly more often than the virus can reproduce, adult viruses never develop. After a twenty-four hour regimen in which the subject’s entire body is immersed in the treatment at specific intervals, any virus can be eliminated. By the most ambitious estimates a human cure is still years away, even for a baby.
It is possible for our technology to create a functional device within a period of less than four months, and a world-wide clinical network of these machines can be started within the year.
I do not have the HIV virus, and I do not know of anybody in my social world who has the disease. My obligation to my society is to present the technology that permits the society to choose how the technology is used.
I want you to be involved. Copy this letter and send it to a legislator. Contact a physicist and persuade the physicist to help. Convince your local AIDS support group to promote this course. First, read the companion article to this one called, The Clinical Application of A Treatment for AIDS , which is more technical, and describes how the clinical process can work world-wide. It also explains why the technology will be instituted in the future if only for commercial use. It justifies the funding for treatment to even those who cannot accept other forms of treatment for victims of HIV.

HIV is affecting the entire world. Many doctors and scientists worldwide have been communicating the importance of taking measures to protect yourself from this deadly virus. Unfortunately, some people don’t seem to be listening. HIV infestation is spreading rapidly in all races, cultures, and economic levels. HIV and AIDS have found their way into all parts of this planet and there have been cases reported among WVU students. It has been the consensus of doctors and scientists worldwide that an effective way to protect yourself from HIV is to abstain from anal, vaginal, or oral sex with people whose HIV status you are unsure of and to refrain from sharing intravenous needles. If you have sex with an unfamiliar partner, a latex condom may reduce the risk of HIV transmission. Symptoms of HIV/AIDS can manifest themselves in a number of ways. Symptoms include: fatigue, night sweats, diarrhea, sores in the mouth, and recurrent fever. However, these symptoms are associated with many other illnesses. If you suspect you are at risk of having HIV, you can get an HIV antibody test. This is a blood test that indicates the presence of antibodies produced by your body that try to fight HIV. If you are considering being tested, talk to a qualified counselor or health care worker. The results of the test may have an impact on your lifestyle. A negative result may open your eyes to a more cautious way of life. A positive diagnosis may require initiation of a powerful medication program (most HIV/AIDS treatments have serious side-effects). Skilled counselors (like those at University Health Services) may help students with this frightening issue. If you have questions about HIV antibody testing or HIV/AIDS in general, call University Health Services at 293-2811. Currently, an HIV positive diagnosis means full blown AIDS is probable. However, some of the worlds’ best scientists are working relentlessly to end the tragic assault of HIV on humanity. Bubonic plague, polio, small pox, and anthrax are some horrible diseases that human resourcefulness has conquered. It may only be a matter of time before HIV succumbs to advancing medical technology - but don’t let that cause you to be careless now!

   Restaurants must follow guidelines established by the health department to ensure cleanliness and good hygiene. Always order meat medium to well done, if it’s served rare, send it back. Check how well cooked poultry or meat is by cutting into the centre of it.

 If it’s the least bit pink or bloody, send it back. Fish should be flaky, not rubbery, when cut. Order well cooked fried eggs, scrambled eggs and avoid that look runny. Caesar salad dressings and hollandaise sauce should also be avoided, if they contain raw eggs. If you’re not sure about the ingredients in a particular dish, ask before ordering.Raw seafood can pose a serious risk of food poisoning. Raw shellfish, like raw meat and poultry, may contain harmful bacteria. It’s a bad idea to eat oysters on the half shell or raw clams. Lightly steamed seafood, like mussels and snails, may also contain harmful bacteria.